“…These substituted materials can be also seen not only as promising bone substitutes but also as drug delivery systems for the controlled-localized delivery, since the ions released during bone substitute resorption could be considered as drugs for bone disease treatment, being able to stimulate the expression of several osteoblastic cell genes [482,483], to induce angiogenesis in vitro and in vivo [484], and to exercise possible antibacterial [485] and inflammatory [486] actions, as evidenced in the case of ionic dissolution products from 45S5 Bioglass ® (e.g., Si, Ca, P, Na) and from other silicate-based glasses [487][488][489][490][491]. Thus it is very important to properly select both the ion doping amount, taking into account its therapeutic level and its release rate, and the ion kinds.…”